| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |